Skip to main content

Table 1 Patient and fracture characteristics for all patients and for young and older

From: Patient-related outcome, fracture displacement and bone mineral density following distal radius fracture in young and older men

  All < 65 years ≥65 years
n = 133 n = 98 n = 35
Age at fracture (years) 54 ± 18 (21–88) 46 ± 14 (21–64) 75 ± 6 (67–88)
BMI (kg/m2) 26.0 ± 3.8 (16.0–40.8) 25.9 ± 3.8 (18.7–40.8) 26.1 ± 3.7 (16.0–31.2)
Charlson Comorbidity Index 1 ± 1 (0–6) 0 ± 1 (0–4) 2 ± 2 (0–6)
Smoking
 - current 22 (17%) 21 (21%) 1 (3%)
 - former 49 (37%) 27 (28%) 22 (63%)
Medication for osteoporosisc 6 (5%) 2 (2%) 4 (11%)
Trauma level - low 84 (63%) 53 (54%) 31 (89%)
Dominant hand fracture 51 (38%) 35 (36%) 16 (46%)
Fracture classification AO
 A 35 (26%) 21 (21%) 14 (40%)
 B 13 (19%) 12 (12%) 1 (3%)
 C 76 (57%) 57 (58%) 19 (56%)
Displacementb
 Initial 46 (39%) 31 (35%) 15 (50%)
 Follow-up 21 (23%) 7 (8%) 14 (41%)
Treatment
 Cast 68 (51%) 49 (50%) 19 (54%)
 Closed reduction & cast 31 (23%) 23 (23%) 8 (23%)
 Surgery 34 (26%) 26 (27%) 8 (23%)
BMD femoral neck (g/cm2) 0.929 ± 0.14 (0.57–1.27) 0.958 ± 0.14 (0.63–1.27) 0.851 ± 0.12 (0.53–1.10)
Osteoporosisa 24 (18%) 15 (15%) 9 (26%)
FRAXBMD (median, IQR)d
 10-year risk of MOF 6.6 (4.5;10) 5.0 (3.9;9.4) 8.8 (6.8;14.8)
 10-year risk of Hip fracture 1.6 (0.6;3.9) 0.7 (0.4;1.7) 3.6 (2;7.7)
  1. Age, height, weight, BMI and BMD are reported as mean (SD) and range; other parameters are reported as number (%), aT-score ≤ −2.5 at femoral neck, total hip or spine, bDisplacement: Dorsal tilt > 10° and/or ulnar variance > 2 mm °, cCalcium/Vitamin D, bisphosphonates, dFRAX calculated for cases from the age of 40 years. The total numbers may vary slightly because of missing data